Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Rat/Bovine/Canine/Human/Non-Human Primates/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Rabphilin 3A (C-Term) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
100 µl in 10 mM HEPES (pH 7.5) , 150 mM NaCl, 100 µg per ml BSA and 50% Glycerol. |
Purification: |
This antibody was antigen affinity purified from pooled serum. |
Dilution Range: |
WB 1:1000IHCICCIP |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
Rph3a |
Gene ID: |
171039 |
Uniprot ID: |
RP3A_RAT |
Immunogen Region: |
C-Term |
Immunogen: |
Synthetic peptide corresponding to amino acid residues from the C-terminal region conjugated to KLH. |
Tissue Specificity | Specifically expressed in brain. |
Post Translational Modifications | Ubiquitinated. Deubiquitinated by CAND1 to prevent its degradation. |
Function | Plays an essential role in docking and fusion steps of regulated exocytosis. At the presynaptic level, RPH3A is recruited by RAB3A to the synaptic vesicle membrane in a GTP-dependent manner where it modulates synaptic vesicle trafficking and calcium-triggered neurotransmitter release. In the post-synaptic compartment, forms a ternary complex with GRIN2A and DLG4 and regulates NMDA receptor stability. Also plays a role in the exocytosis of arginine vasopressin hormone. |
Protein Name | Rabphilin-3aExophilin-1 |
Cellular Localisation | Cytoplasmic VesicleSecretory VesicleSynaptic Vesicle MembraneCell ProjectionDendritic SpinePostsynaptic Cell MembraneMembranePeripheral Membrane Protein |
Alternative Antibody Names | Anti-Rabphilin-3a antibodyAnti-Exophilin-1 antibodyAnti-Rph3a antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance